ABVC BioPharma Inc (ABVC)

Finanzdaten der ABVC BioPharma Inc-Aktie (ABVC)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	86.37% 0.00217	0.0159	0.00611	0.1283	0.589
Cost Of Revenue	370.07% 0.1392	0.0296	0.073	0.0602	0.2654
Gross Profit	898.11% -0.137	-0.0137	-0.0669	0.068	0.3236
Operating Expenses	14.79% 1.8246	2.1411	2.127	1.9742	3.4566
Interest Income/Expense	9.46% 1.1033	1.2186	0.1148	0.0567	0.1345
Benefits Costs and Expenses	6.75% 3.1566	3.385	2.2396	2.0255	4.127
Costs And Expenses	6.75% 3.1566	3.385	2.2396	2.0255	4.127
Operating Income/Loss	8.97% -1.9616	-2.1549	-2.1938	-1.9062	-3.133
Interest And Debt Expense	0.06% 0.00501	0.00502	0.00517	0.0049	-
Income/Loss From Continuing Operations Before Tax	6.37% -3.1544	-3.3691	-2.2335	-1.8972	-3.538
Income Tax Expense/Benefit, Deferred	228.93% 0.1514	-0.1174	-	-	0.896
Income Tax Expense/Benefit	17,649% 0.1753	-0.000999	0.0817	-	0.9629
Income/Loss From Continuing Operations After Tax	1.14% -3.3298	-3.3681	-2.3152	-1.8972	-4.5009
Net Income/Loss	1.14% -3.3298	-3.3681	-2.3152	-1.8972	-4.5009
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	332.76% -0.2188	-0.0506	-0.0517	-0.0735	0.363
Basic Average Shares	80.76% 0.7802	4.0553	3.3087	33.08	0.4713
Diluted Average Shares	80.76% 0.7802	4.0553	3.3087	33.08	-1.0399
Basic Earnings Per Share	57.32% -0.35	-0.82	-0.68	-0.06	-0.15
Diluted Earnings Per Share	57.32% -0.35	-0.82	-0.68	-0.06	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-